Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Ocular Blood Flow in Colorectal Cancer Patients
- Status
- TERMINATED
- Phase
- N/A
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas
- Status
- COMPLETED
- Phase
- N/A
FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type
- Status
- COMPLETED
- Phase
- PHASE2
Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis
- Status
- WITHDRAWN
- Phase
- PHASE2
Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR
- Status
- COMPLETED
- Phase
- N/A
Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting
- Status
- COMPLETED
- Phase
- N/A
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).
- Status
- UNKNOWN
- Phase
- PHASE2
Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient
- Status
- COMPLETED
- Phase
- PHASE2
Improving Informed Consent for Palliative Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2